SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-19-002642
Filing Date
2019-04-25
Accepted
2019-04-25 16:10:15
Documents
6
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a_042519.htm DEFA14A 12860
2 GRAPHIC logo.jpg GRAPHIC 33624
3 GRAPHIC card_01.jpg GRAPHIC 188034
4 GRAPHIC card_02.jpg GRAPHIC 302148
5 GRAPHIC card_03.jpg GRAPHIC 113512
6 GRAPHIC card_04.jpg GRAPHIC 63933
  Complete submission text file 0001171843-19-002642.txt   978494
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 19767535
SIC: 3841 Surgical & Medical Instruments & Apparatus